Detalhe da pesquisa
1.
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.
J Infect Dis
; 228(3): 287-298, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702771
2.
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
J Infect Dis
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019956
3.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561027
4.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036397
5.
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med
; 383(20): 1920-1931, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663912
6.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med
; 383(25): 2427-2438, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991794
7.
Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol.
BMC Pregnancy Childbirth
; 22(1): 402, 2022 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550037
8.
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med
; 384(23): 2259-2261, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822494
9.
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med
; 384(1): 80-82, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270381
10.
Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.
Clin Infect Dis
; 63(suppl 3): S110-S115, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742642
11.
A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis.
Clin Infect Dis
; 61Suppl 3: S164-72, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409279
12.
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.
J Infect Dis
; 205 Suppl 2: S199-208, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22448023
13.
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.
NPJ Vaccines
; 8(1): 36, 2023 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36899062
14.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034641
15.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333252
16.
Reply to Raoult.
Clin Infect Dis
; 64(7): 984, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28362943
17.
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.
Clin Infect Dis
; 55(4): 572-81, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22615332
18.
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
Am J Respir Crit Care Med
; 184(8): 972-9, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21737585
19.
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis.
Res Sq
; 2022 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35547849
20.
Harnessing Novel Quantitative Pharmacology Approaches to Optimize the Treatment of Children With Tuberculosis.
Clin Infect Dis
; 63(suppl 3): S61-S62, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742635